Levoﬂoxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection

NCT01742429 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Cure Rate of Helicobacter Pylori Infection

Interventions

DRUG: Proton pump inhibitor
DRUG: Bismuth subsalicylate
DRUG: Metronidazole
DRUG: Tetracycline
DRUG: Amoxicillin
DRUG: Levofloxacin

Sponsor

Shanghai Jiao Tong University School of Medicine